Compare Oscar Health Inc (OSCR) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Ross Stores, Inc. — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Ross Stores, Inc. trades at $222.41 (market cap $71.94B). The key difference: Ross Stores, Inc. is far larger — about 7× Oscar Health Inc's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Ross Stores, Inc. for 48 Days on average.
| OSCR | ROST | |
|---|---|---|
Market Cap | $10.22B | $71.94B |
Volume | 4,123,394 | 2,002,519 |
Sector | Health | Consumer Cyclical |
52-Week High | $33.81 | $255.23 |
52-Week Low | $10.85 | $147.71 |
Typical Hold Time | 15 Days | 48 Days |
Enterprise Value | $6.57B | $72.39B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Ross Stores (ROST) trades at $225.2, down 0.15% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast. Revenue grew to $21.13B in 2025, and net income margin improved to 10.85%. Analyst consensus is bullish with a $274.14 price target, though technical indicators show resistance near $226.
The outlook for ROST is positive due to robust earnings performance, store expansion initiatives, and strong profitability metrics like a 42.63% ROE. Risks include competitive pressures and rising costs, but institutional buying and a high analyst buy rating (63.83%) support upside potential. The stock presents a compelling opportunity for growth investors seeking value in the discount retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
